| Quarter | Call date | Disclosure | Financial quality | Kept | Missed | |
|---|---|---|---|---|---|---|
| Q2'26 | July 28, 2026 | 4/12 | 2 high, 4 medium, 2 low flags | 3 | 0 | Call sheet → |
| Q1'26 | April 28, 2026 | 9/12 | 1 high, 2 medium, 3 low flags | 4 | 0 | Call sheet → |
| Q4'25 | February 10, 2026 | 7/12 | 2 medium, 4 low flags | 3 | 1 | Call sheet → |
| Marked | Status | Promise |
|---|---|---|
| Q2'26 | Delivered | Maintain dividend and share repurchases Strong FCF generation supporting capital return |
| Q2'26 | Delivered | Continue investing in Asia Pacific for long-term Still destroying price/mix to buy volume, as promised |
| Q2'26 | Exceeded | Comparable EPS growth of 8-9% Raised to 9-10%, but mostly from tax rate change not operations |
| Q2'26 | Pending | Organic revenue growth of 4-5% Raised to ~5%, tracking at 8% in H1 but H2 will decelerate |
| Q2'26 | Pending | Balanced volume and price/mix growth for full year On track so far with 3% volume, 2% price/mix in H1 |
| Q2'26 | Pending | Fairlife Webster capacity to start aligning in Q2 Now saying it will 'continue ramping through the year', timeline slipping |
| Q1'26 | Delivered | Fair life capacity additions in 2026 Webster capacity confirmed to start Q2 as planned |
| Q1'26 | Pending | CCBA sale closing second half 2026 Maintained same timeline, subject to regulatory approvals |
| Q1'26 | Pending | Managing commodity pressures as manageable Called out tea/coffee pressures but maintained manageable stance |
| Q1'26 | Exceeded | Comparable EPS growth of 5-6% currency-neutral Now guiding 6-7% currency-neutral, raised by 100 bps |
| Q1'26 | Delivered | Volume as key priority with balanced growth algorithm Achieved 3% volume growth across all segments as promised |
| Q1'26 | Exceeded | Organic revenue growth of 4-5% for 2026 Q1 delivered 10% organic growth, though aided by 6 extra days and concentrate timing |
| Q4'25 | Exceeded | Generate at least $9.8B free cash flow in 2025 Delivered $11.4B excluding fairlife payment |
| Q4'25 | Exceeded | Maintain value share gains for 18th consecutive quarter Extended to 19 quarters of value share gains |
| Q4'25 | Missed | Drive volume growth in key emerging markets like India India continues to underperform with no clear recovery timeline given |
| Q4'25 | Mixed | Navigate complex external environment in key markets Some markets improved (Brazil) but others deteriorated (Asia Pacific) |
| Q4'25 | Pending | Volume as key priority with more balanced growth Still talking about getting to balance in 2026 - haven't achieved it yet |
| Q4'25 | Delivered | Deliver on 2025 guidance for top line and bottom line Hit organic revenue 5-6% range and EPS ~3% growth target |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.